Acetylcysteine and budesonide for the treatment of refractory Mycoplasma pneumoniae pneumonia in children: a clinical observation

Table 4 Clinical efficacy of three groups of children with RMPP

Groups	Cases	Remarkable (%)	Effective (%)	Invalid (%)	X²	P
Budesonide	24	33.33	41.67	25.00	9.78	0.044
Ambroxol + budesonide	28	35.71	42.86	21.43
Acetylcysteine + budesonide	30	66.67	30.00	3.33

ISSN: 1824-7288